HUTCHMED (China) (0013.HK) Earnings Analysis

HUTCHMED (China) (0013.HK) next reports earnings on 2026-07-30, consensus EPS 0.2353 HKD. Last quarter (2026-03-05) it missed with EPS 0.00856 HKD vs 3.89 HKD est (-99.8%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E 4.17.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 0013.HK next report earnings?

Next earnings date2026-07-30
Consensus EPS estimate0.2353 HKD
Revenue estimate2.40B

0013.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-050.00856 HKD3.89 HKD-99.8%Miss
2025-03-192.03 HKD0.06217 HKD+3165.2%Beat
2025-02-190.05306 HKDn/an/an/a
2024-09-300.05305 HKDn/an/an/a
2024-07-310.1155 HKD-0.61314 HKD+118.8%Beat

Beat rate: 2/3 (67%) over reported quarters with consensus data.

0013.HK valuation and analyst view

Trailing P/E4.17
Trailing EPS0.04534 HKD
Price / book18.42
Dividend yield0.00%
Market cap15.33B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is HUTCHMED (China) (0013.HK)'s next earnings date?

HUTCHMED (China) is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.2353 HKD and revenue estimate of 2.40B.

Did 0013.HK beat earnings last quarter?

In its 2026-03-05 report, 0013.HK posted EPS of 0.00856 HKD versus a 3.89 HKD estimate — a miss of 99.8%.

What is 0013.HK's earnings track record?

Over the last 3 reported quarters with consensus data, 0013.HK beat estimates 2 times (67%).

What is 0013.HK's current P/E ratio and EPS?

0013.HK trades at a trailing P/E of 4.17 on trailing EPS of 0.04534033043761203 HKD.

What do analysts rate 0013.HK?

0013.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.